Malignant Kidney Neoplasm — Trials

Malignant Kidney Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

2,142 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 453
Recruiting: 231
Ph III recruiting: 18
Growth YoY: +7.4%
Industry share: 29%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.3%
Trials / 1,000 deaths: 30.7 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (339)

clinicaltrialsPublishedShowing 1–50 of 75 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05432232	The HistoSonics Investigational System for Treatment of Primary Solid Renal Tumors Using Histotripsy(CAIN)	completed	N/A	20	HistoSonics, Inc.INDUSTRY	1	Sep 11, 2026	clinicaltrials
NCT03948724	Impact of Therapeutic Patient Education on the Toxicity of Immune Checkpoint Inhibitors in Oncology(EDHITO)	completed	N/A	412	Institut Cancerologie de l'OuestOTHER	1	Aug 31, 2026